CTLA4 and neoplasm: Several years later, in 1995 Krummel et al. and Leach et al. showed that CTLA-4 negatively regulates T-cell activation and concluded that inhibitory antibodies against CTLA-4 can be used to enhance anti-tumour immunity [56,57].